Literature DB >> 6197808

Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants.

G N Rogers, T J Pritchett, J L Lane, J C Paulson.   

Abstract

Human and animal (avian and equine) influenza A virus isolates of the H3 serotype exhibit marked differences in their ability to bind specific sialyloligosaccharide sequences that serve as cell surface receptor determinants (G. Rogers and J. Paulson, 1983, Virology 127, 361-373). Whereas human isolates of this subtype strongly agglutinate enzymatically modified human erythrocytes containing the terminal SA alpha 2,6Gal sequence, avian and equine isolates preferentially agglutinate erythrocytes bearing the SA alpha 2, 3Gal sequence. As shown in this report, a glycoprotein found in horse serum, alpha 2-macroglobulin, is a potent inhibitor of viral adsorption to the cell surface for human H3 isolates. In contrast, avian and equine isolates are poorly inhibited suggesting a correlation between receptor specificity and inhibitor sensitivity. Growth of a human H3 isolate (A/Memphis/102/72) on MDCK cells in the presence of horse serum resulted in an overall shift in the virus receptor specificity from preferential binding of the SA alpha 2,6Gal linkage to preferential binding of the SA alpha 2,3Gal linkage characteristic of avian and equine isolates. Clonally isolated variants of A/Memphis/102/72 grown in the presence or absence of horse serum exhibited binding properties that account for those observed in the field isolates. Clones which preferentially bound the SA alpha 2,6Gal linkage, like the parent human virus, were very sensitive to inhibition of hemagglutination by horse serum and equine alpha 2-macroglobulin. In contrast, receptor variants which preferentially bound the SA alpha 2,3Gal linkage, like the avian and equine isolate, were insensitive to such inhibitors. None of the variants was very sensitive to inhibition of hemagglutination by human alpha 2-macroglobulin. These results suggest that the presence, in vivo, of a glycoprotein inhibitor such as equine alpha 2-macroglobulin could suppress infection of influenza viruses bearing an H3 hemagglutinin with a SA alpha 2,6Gal specific, inhibitor sensitive phenotype, allowing growth to predominance of a virus which is SA alpha 2,3Gal specific and inhibitor insensitive as found in avian and equine isolates.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197808     DOI: 10.1016/0042-6822(83)90507-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  73 in total

1.  Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals.

Authors:  M Matrosovich; A Tuzikov; N Bovin; A Gambaryan; A Klimov; M R Castrucci; I Donatelli; Y Kawaoka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques.

Authors:  Tokiko Watanabe; Kyoko Shinya; Shinji Watanabe; Masaki Imai; Masato Hatta; Chengjun Li; Ben F Wolter; Gabriele Neumann; Anthony Hanson; Makoto Ozawa; Shinya Yamada; Hirotaka Imai; Saori Sakabe; Ryo Takano; Kiyoko Iwatsuki-Horimoto; Maki Kiso; Mutsumi Ito; Satoshi Fukuyama; Eiryo Kawakami; Takeo Gorai; Heather A Simmons; Daniel Schenkman; Kevin Brunner; Saverio V Capuano; Jason T Weinfurter; Wataru Nishio; Yoshimasa Maniwa; Tatsuhiko Igarashi; Akiko Makino; Emily A Travanty; Jieru Wang; Anette Kilander; Susanne G Dudman; M Suresh; Robert J Mason; Olav Hungnes; Thomas C Friedrich; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Mutation tryptophan to leucine at position 222 of haemagglutinin could facilitate H3N2 influenza A virus infection in dogs.

Authors:  Guohua Yang; Shoujun Li; Sherry Blackmon; Jianqiang Ye; Konrad C Bradley; Jim Cooley; Dave Smith; Larry Hanson; Carol Cardona; David A Steinhauer; Richard Webby; Ming Liao; Xiu-Feng Wan
Journal:  J Gen Virol       Date:  2013-09-01       Impact factor: 3.891

4.  Phenotypic Effects of Substitutions within the Receptor Binding Site of Highly Pathogenic Avian Influenza H5N1 Virus Observed during Human Infection.

Authors:  Dirk Eggink; Monique Spronken; Roosmarijn van der Woude; Jocynthe Buzink; Frederik Broszeit; Ryan McBride; Hana A Pawestri; Vivi Setiawaty; James C Paulson; Geert-Jan Boons; Ron A M Fouchier; Colin A Russell; Menno D de Jong; Robert P de Vries
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

5.  Unique Structural Features of Influenza Virus H15 Hemagglutinin.

Authors:  Netanel Tzarum; Ryan McBride; Corwin M Nycholat; Wenjie Peng; James C Paulson; Ian A Wilson
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

6.  Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies.

Authors:  J W Yewdell; A J Caton; W Gerhard
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

7.  Effect of neuraminidase treatment of cells and effect of soluble glycoproteins on type 3 reovirus attachment to murine L cells.

Authors:  J R Gentsch; A F Pacitti
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

8.  Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses.

Authors:  Chengjun Li; Masato Hatta; Shinji Watanabe; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

9.  A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior.

Authors:  R Freund; R L Garcea; R Sahli; T L Benjamin
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

Review 10.  H5N1 receptor specificity as a factor in pandemic risk.

Authors:  James C Paulson; Robert P de Vries
Journal:  Virus Res       Date:  2013-04-22       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.